Quick Answer
BeOne Medicines Ltd. reported Stockholders Equity of $4.36 billion for fiscal year 2025.
BeOne Medicines Ltd. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.36B | +30.9% |
| 2024 | $3.33B | -5.8% |
| 2023 | $3.54B | -19.3% |
| 2022 | $4.38B | -28.5% |
| 2021 | $6.13B | +58.5% |
| 2020 | $3.87B | +302.1% |
| 2019 | $962.21M | -44.7% |
| 2018 | $1.74B | +159.7% |
| 2017 | $669.81M | +89.8% |
| 2016 | $352.91M | +446.8% |
| 2015 | -$101.77M | -91.9% |
| 2014 | -$53.04M | -43.5% |
| 2013 | -$36.96M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.13B | +20.2% | +9.5% |
| June 30, 2025 | $3.77B | +12.0% | +7.7% |
| March 31, 2025 | $3.50B | +4.1% | +5.0% |
| December 31, 2024 | $3.33B | -5.8% | -3.0% |
| September 30, 2024 | $3.44B | -8.7% | +2.1% |
| June 30, 2024 | $3.37B | -11.4% | +0.2% |
| March 31, 2024 | $3.36B | -19.2% | -5.0% |
| December 31, 2023 | $3.54B | -19.3% | -6.0% |
- BeOne Medicines Ltd. showed an increase of +30.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2025 period, BeOne Medicines Ltd.’s stockholders equity has grown by 11900.1% (from -$36.96 million to $4.36 billion).
- The most recent figure is from BeOne Medicines Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: